Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongshan Bailing Biotechnology is a specialized biotechnology firm focused on the research, development, and manufacturing of recombinant proteins and antibodies. Headquartered in Zhongshan, China, the company provides high-purity cytokines, growth factors, and diagnostic antigens to the global life sciences and in vitro diagnostics (IVD) sectors. Their core expertise lies in multiple protein expression platforms, including bacterial, yeast, and mammalian cell systems, ensuring optimal bioactivity for research and clinical applications. Bailing Biotech's products are widely utilized in cell therapy manufacturing, vaccine development, and the creation of diagnostic assay kits. The company is committed to providing high-quality biological raw materials to accelerate biomedical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 中山百灵生物技术.